Autologous neoplastic isto-cryoprecipitates as immuno-stimulating treatment in 100 urological cancer patients.
作者信息
Marten-Perolino R, Cocimano V, Botto A, Buffa G, Riggi E, Trapani C
机构信息
Ospedale Mauriziano Umberto I Di Torino.
出版信息
J Exp Pathol. 1987 Summer;3(4):587-92.
PMID:3454806
Abstract
摘要
相似文献
1
Autologous neoplastic isto-cryoprecipitates as immuno-stimulating treatment in 100 urological cancer patients.
J Exp Pathol. 1987 Summer;3(4):587-92.
2
The cancer associated antigen test as an index to failure of complete removal of urological cancers.
Trans Am Assoc Genitourin Surg. 1972;64:85-7.
3
[Response criteria for urological cancer treatment].
Nihon Hinyokika Gakkai Zasshi. 1992 Apr;83(4):447-72.
4
The systemic therapy of urologic cancer.
Conn Med. 1980 Apr;44(4):217-24.
5
[Serum and urinary tissue polypeptide antigen (TPA) in patients with urological cancer].
Hinyokika Kiyo. 1985 Dec;31(12):2113-9.
6
Carcinoembryonic antigen and urothelial carcinoma.
Br J Urol. 1973 Feb;45(1):88-92.
7
[Immunologic aspects in urologic tumors].
Med Klin. 1980 Jun 6;75(12):436-41.
8
Molecular research in cancer: future clinical applications.
Acta Urol Belg. 1996 May;64(2):53-5.
9
[Urologic tumors in old age].
Tijdschr Gerontol Geriatr. 1986 Apr;17(2):65-8.
10
The role of imaging in the surveillance of urologic malignancies.
Urol Clin North Am. 2006 Aug;33(3):377-96. doi: 10.1016/j.ucl.2006.03.001.
Zotero 插件